Chronic villitis of unknown etiology

Abstract The diagnosis of chronic villitis of unknown etiology (CVUE), characterized by focal areas of inflammation with mononuclear cells and areas of fibrinoid necrosis in chorionic villi, can only be set-up after exclusion of a latent maternal-fetal transmission of infectious agents by sophistica...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of obstetrics & gynecology and reproductive biology 2008-01, Vol.136 (1), p.9-15
1. Verfasser: Boog, Georges
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 15
container_issue 1
container_start_page 9
container_title European journal of obstetrics & gynecology and reproductive biology
container_volume 136
creator Boog, Georges
description Abstract The diagnosis of chronic villitis of unknown etiology (CVUE), characterized by focal areas of inflammation with mononuclear cells and areas of fibrinoid necrosis in chorionic villi, can only be set-up after exclusion of a latent maternal-fetal transmission of infectious agents by sophisticated techniques such as polymerase chain reaction. Significant associations of CVUE with maternal body mass index, multigravidity and ethnicity were reported. While a fetal origin of the inflammatory cells has been evoked, there are many more arguments drawn from histopathology and immunohistology for a maternal immune response against the foreign fetal allograft. CVUE is detected in 7–33% of placentas, mainly after idiopathic intrauterine growth retardation, unexplained prematurity, preeclampsia, perinatal asphyxia and intrauterine fetal death. CVUE is also more frequent in pregnancies affected by autoimmune or alloimmune diseases. Considering the high rate of recurrences after an index case of CVUE, we would suggest to associate aspirine and corticosteroids in further pregnancies, a regimen that was successful in our experience but must be confirmed by other studies. The same is true for the alleviated inflammatory immunologic response recently obtained by a weekly use of maternal intravenous immunoglobulins.
doi_str_mv 10.1016/j.ejogrb.2007.06.018
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70187480</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0301211507002849</els_id><sourcerecordid>70187480</sourcerecordid><originalsourceid>FETCH-LOGICAL-c445t-3648d57b531fb116bff9312f92c4e887e568c084df40f8e2f110eda362ef2f383</originalsourceid><addsrcrecordid>eNqFkc1u1DAURi0EotPCGyA0C8ou4fontrNBQqNSkCqxKKytxLkuTj1xsZOiefs6mpEqscEbb8732fdcQt5RqClQ-WmscYx3qa8ZgKpB1kD1C7KhWrFKyUa8JBvgQCtGaXNGznMeoRzO29fkjCqpuRZyQz7sfqc4ebt99CH42edtdNtlup_i32mLs48h3h3ekFeuCxnfnu4L8uvr1c_dt-rmx_X33ZebygrRzBWXQg-N6htOXU-p7J1rOWWuZVag1gobqS1oMTgBTiNzlAIOHZcMHXNc8wvy8dj7kOKfBfNs9j5bDKGbMC7ZqDKiEhoKKI6gTTHnhM48JL_v0sFQMKsdM5qjHbPaMSBNiZbY-1P_0u9xeA6ddBTg8gR02XbBpW6yPj9zbat1S9f3Px85LDYePSaTrcfJ4uAT2tkM0f_vJ_8W2ODLGrpwjwfMY1zSVEwbajIzYG7XTa6LBAXAtGj5E48Al-4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70187480</pqid></control><display><type>article</type><title>Chronic villitis of unknown etiology</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Boog, Georges</creator><creatorcontrib>Boog, Georges</creatorcontrib><description>Abstract The diagnosis of chronic villitis of unknown etiology (CVUE), characterized by focal areas of inflammation with mononuclear cells and areas of fibrinoid necrosis in chorionic villi, can only be set-up after exclusion of a latent maternal-fetal transmission of infectious agents by sophisticated techniques such as polymerase chain reaction. Significant associations of CVUE with maternal body mass index, multigravidity and ethnicity were reported. While a fetal origin of the inflammatory cells has been evoked, there are many more arguments drawn from histopathology and immunohistology for a maternal immune response against the foreign fetal allograft. CVUE is detected in 7–33% of placentas, mainly after idiopathic intrauterine growth retardation, unexplained prematurity, preeclampsia, perinatal asphyxia and intrauterine fetal death. CVUE is also more frequent in pregnancies affected by autoimmune or alloimmune diseases. Considering the high rate of recurrences after an index case of CVUE, we would suggest to associate aspirine and corticosteroids in further pregnancies, a regimen that was successful in our experience but must be confirmed by other studies. The same is true for the alleviated inflammatory immunologic response recently obtained by a weekly use of maternal intravenous immunoglobulins.</description><identifier>ISSN: 0301-2115</identifier><identifier>EISSN: 1872-7654</identifier><identifier>DOI: 10.1016/j.ejogrb.2007.06.018</identifier><identifier>PMID: 17683846</identifier><identifier>CODEN: EOGRAL</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Biological and medical sciences ; Chorionic Villi - pathology ; Chronic villitis of unknown etiology ; Diseases of mother, fetus and pregnancy ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Inflammation ; Medical sciences ; Obstetrics and Gynecology ; Placenta Diseases - etiology ; Placenta Diseases - prevention &amp; control ; Pregnancy ; Pregnancy complications ; Pregnancy Complications - etiology ; Pregnancy Complications - prevention &amp; control ; Pregnancy. Fetus. Placenta ; Prevention ; Recurrences ; Risk Factors ; Secondary Prevention</subject><ispartof>European journal of obstetrics &amp; gynecology and reproductive biology, 2008-01, Vol.136 (1), p.9-15</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2007 Elsevier Ireland Ltd</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c445t-3648d57b531fb116bff9312f92c4e887e568c084df40f8e2f110eda362ef2f383</citedby><cites>FETCH-LOGICAL-c445t-3648d57b531fb116bff9312f92c4e887e568c084df40f8e2f110eda362ef2f383</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0301211507002849$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19988910$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17683846$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boog, Georges</creatorcontrib><title>Chronic villitis of unknown etiology</title><title>European journal of obstetrics &amp; gynecology and reproductive biology</title><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><description>Abstract The diagnosis of chronic villitis of unknown etiology (CVUE), characterized by focal areas of inflammation with mononuclear cells and areas of fibrinoid necrosis in chorionic villi, can only be set-up after exclusion of a latent maternal-fetal transmission of infectious agents by sophisticated techniques such as polymerase chain reaction. Significant associations of CVUE with maternal body mass index, multigravidity and ethnicity were reported. While a fetal origin of the inflammatory cells has been evoked, there are many more arguments drawn from histopathology and immunohistology for a maternal immune response against the foreign fetal allograft. CVUE is detected in 7–33% of placentas, mainly after idiopathic intrauterine growth retardation, unexplained prematurity, preeclampsia, perinatal asphyxia and intrauterine fetal death. CVUE is also more frequent in pregnancies affected by autoimmune or alloimmune diseases. Considering the high rate of recurrences after an index case of CVUE, we would suggest to associate aspirine and corticosteroids in further pregnancies, a regimen that was successful in our experience but must be confirmed by other studies. The same is true for the alleviated inflammatory immunologic response recently obtained by a weekly use of maternal intravenous immunoglobulins.</description><subject>Biological and medical sciences</subject><subject>Chorionic Villi - pathology</subject><subject>Chronic villitis of unknown etiology</subject><subject>Diseases of mother, fetus and pregnancy</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Medical sciences</subject><subject>Obstetrics and Gynecology</subject><subject>Placenta Diseases - etiology</subject><subject>Placenta Diseases - prevention &amp; control</subject><subject>Pregnancy</subject><subject>Pregnancy complications</subject><subject>Pregnancy Complications - etiology</subject><subject>Pregnancy Complications - prevention &amp; control</subject><subject>Pregnancy. Fetus. Placenta</subject><subject>Prevention</subject><subject>Recurrences</subject><subject>Risk Factors</subject><subject>Secondary Prevention</subject><issn>0301-2115</issn><issn>1872-7654</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u1DAURi0EotPCGyA0C8ou4fontrNBQqNSkCqxKKytxLkuTj1xsZOiefs6mpEqscEbb8732fdcQt5RqClQ-WmscYx3qa8ZgKpB1kD1C7KhWrFKyUa8JBvgQCtGaXNGznMeoRzO29fkjCqpuRZyQz7sfqc4ebt99CH42edtdNtlup_i32mLs48h3h3ekFeuCxnfnu4L8uvr1c_dt-rmx_X33ZebygrRzBWXQg-N6htOXU-p7J1rOWWuZVag1gobqS1oMTgBTiNzlAIOHZcMHXNc8wvy8dj7kOKfBfNs9j5bDKGbMC7ZqDKiEhoKKI6gTTHnhM48JL_v0sFQMKsdM5qjHbPaMSBNiZbY-1P_0u9xeA6ddBTg8gR02XbBpW6yPj9zbat1S9f3Px85LDYePSaTrcfJ4uAT2tkM0f_vJ_8W2ODLGrpwjwfMY1zSVEwbajIzYG7XTa6LBAXAtGj5E48Al-4</recordid><startdate>20080101</startdate><enddate>20080101</enddate><creator>Boog, Georges</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080101</creationdate><title>Chronic villitis of unknown etiology</title><author>Boog, Georges</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c445t-3648d57b531fb116bff9312f92c4e887e568c084df40f8e2f110eda362ef2f383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Biological and medical sciences</topic><topic>Chorionic Villi - pathology</topic><topic>Chronic villitis of unknown etiology</topic><topic>Diseases of mother, fetus and pregnancy</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Medical sciences</topic><topic>Obstetrics and Gynecology</topic><topic>Placenta Diseases - etiology</topic><topic>Placenta Diseases - prevention &amp; control</topic><topic>Pregnancy</topic><topic>Pregnancy complications</topic><topic>Pregnancy Complications - etiology</topic><topic>Pregnancy Complications - prevention &amp; control</topic><topic>Pregnancy. Fetus. Placenta</topic><topic>Prevention</topic><topic>Recurrences</topic><topic>Risk Factors</topic><topic>Secondary Prevention</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boog, Georges</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of obstetrics &amp; gynecology and reproductive biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boog, Georges</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chronic villitis of unknown etiology</atitle><jtitle>European journal of obstetrics &amp; gynecology and reproductive biology</jtitle><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><date>2008-01-01</date><risdate>2008</risdate><volume>136</volume><issue>1</issue><spage>9</spage><epage>15</epage><pages>9-15</pages><issn>0301-2115</issn><eissn>1872-7654</eissn><coden>EOGRAL</coden><abstract>Abstract The diagnosis of chronic villitis of unknown etiology (CVUE), characterized by focal areas of inflammation with mononuclear cells and areas of fibrinoid necrosis in chorionic villi, can only be set-up after exclusion of a latent maternal-fetal transmission of infectious agents by sophisticated techniques such as polymerase chain reaction. Significant associations of CVUE with maternal body mass index, multigravidity and ethnicity were reported. While a fetal origin of the inflammatory cells has been evoked, there are many more arguments drawn from histopathology and immunohistology for a maternal immune response against the foreign fetal allograft. CVUE is detected in 7–33% of placentas, mainly after idiopathic intrauterine growth retardation, unexplained prematurity, preeclampsia, perinatal asphyxia and intrauterine fetal death. CVUE is also more frequent in pregnancies affected by autoimmune or alloimmune diseases. Considering the high rate of recurrences after an index case of CVUE, we would suggest to associate aspirine and corticosteroids in further pregnancies, a regimen that was successful in our experience but must be confirmed by other studies. The same is true for the alleviated inflammatory immunologic response recently obtained by a weekly use of maternal intravenous immunoglobulins.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>17683846</pmid><doi>10.1016/j.ejogrb.2007.06.018</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0301-2115
ispartof European journal of obstetrics & gynecology and reproductive biology, 2008-01, Vol.136 (1), p.9-15
issn 0301-2115
1872-7654
language eng
recordid cdi_proquest_miscellaneous_70187480
source MEDLINE; Elsevier ScienceDirect Journals
subjects Biological and medical sciences
Chorionic Villi - pathology
Chronic villitis of unknown etiology
Diseases of mother, fetus and pregnancy
Female
Gynecology. Andrology. Obstetrics
Humans
Inflammation
Medical sciences
Obstetrics and Gynecology
Placenta Diseases - etiology
Placenta Diseases - prevention & control
Pregnancy
Pregnancy complications
Pregnancy Complications - etiology
Pregnancy Complications - prevention & control
Pregnancy. Fetus. Placenta
Prevention
Recurrences
Risk Factors
Secondary Prevention
title Chronic villitis of unknown etiology
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T16%3A39%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chronic%20villitis%20of%20unknown%20etiology&rft.jtitle=European%20journal%20of%20obstetrics%20&%20gynecology%20and%20reproductive%20biology&rft.au=Boog,%20Georges&rft.date=2008-01-01&rft.volume=136&rft.issue=1&rft.spage=9&rft.epage=15&rft.pages=9-15&rft.issn=0301-2115&rft.eissn=1872-7654&rft.coden=EOGRAL&rft_id=info:doi/10.1016/j.ejogrb.2007.06.018&rft_dat=%3Cproquest_cross%3E70187480%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70187480&rft_id=info:pmid/17683846&rft_els_id=1_s2_0_S0301211507002849&rfr_iscdi=true